# Neurocognitive Effects of FMT in MDD Patients With and Without IBS

> **NCT05174273** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Valerie Taylor** · enrollment: 133 (actual)

## Conditions studied

- Major Depressive Disorder
- Irritable Bowel Syndrome

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplantation

## Key facts

- **NCT ID:** NCT05174273
- **Lead sponsor:** Valerie Taylor
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-06
- **Primary completion:** 2024-10-21
- **Final completion:** 2026-10-21
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05174273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05174273, "Neurocognitive Effects of FMT in MDD Patients With and Without IBS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05174273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*